Stocknear Logo Stocknear
ctrl K
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
  • Login
    Stocknear Logo Stocknear
    Start new chat
    Home
    Hedge Funds
    News
    Pricing Plan

    Prothena Corporation (PRTA)

    NASDAQ: PRTA · Real-Time Price · USD
    5.41
    0.35 (6.92%)
    At close: Jun 06, 2025, 3:59 PM
    5.44
    0.65%
    After-hours: Jun 06, 2025, 05:34 PM EDT
      Overview Financials Statistics Metrics Forecast Dark Pool Options Insider Dividends History Profile
      Insider Trading 13F Institute Transcripts

    Transcripts

    Pro Subscription

    Upgrade now for unlimited access to all data, tools and no ads.

    PRTA News

    • 11 days ago - Prothena's Late-Stage Study for AL Amyloidosis Fails, Stock Down - zacks.com
    • 11 days ago - Why Is Prothena Stock Trading Lower On Tuesday? - benzinga.com
    • 15 days ago - Prothena Announces Phase 3 AFFIRM-AL Clinical Trial for Birtamimab in Patients with AL Amyloidosis Did Not Meet Primary Endpoint - businesswire.com
    • 29 days ago - Prothena Q1 Earnings Miss Estimates, Focus on Key Readouts in 2025 - zacks.com
    • 29 days ago - Top 3 Health Care Stocks That Are Preparing To Pump This Quarter - benzinga.com
    • 30 days ago - Prothena (PRTA) Reports Q1 Loss, Misses Revenue Estimates - zacks.com
    • 30 days ago - Prothena Reports First Quarter 2025 Financial Results and Business Highlights - businesswire.com
    • 37 days ago - Prothena to Report First Quarter 2025 Financial Results on May 8 - businesswire.com

    Add to Watchlist

    Sections

    • Stocks
    • IPOs
    • ETFs
    • Blog

    Services

    • Pricing Plan
    • Discord Bot
    • Free Newsletter
    • Get Support

    Website

    • Login
    • FAQ
    • Sitemap
    • Learning Center
    • Affiliate Program

    Company

    • About
    • Contact Us
    • Terms of Use
    • Privacy Policy
    • Data Disclaimer
    • Imprint

    © 2025 Stocknear. All rights reserved.